Explaining the Increase in the Prevalence of Autism Spectrum Disorders: The Proportion Attributable to Changes in Reporting Practices | Autism Spectrum Disorders | JAMA Pediatrics | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.204.227.34. Please contact the publisher to request reinstatement.
1.
Blaxill  MF.  What’s going on? the question of time trends in autism.  Public Health Rep. 2004;119(6):536-551.PubMedGoogle ScholarCrossref
2.
Atladóttir  HO, Parner  ET, Schendel  D, Dalsgaard  S, Thomsen  PH, Thorsen  P.  Time trends in reported diagnoses of childhood neuropsychiatric disorders: a Danish cohort study.  Arch Pediatr Adolesc Med. 2007;161(2):193-198.PubMedGoogle ScholarCrossref
3.
Weintraub  K.  The prevalence puzzle: autism counts.  Nature. 2011;479(7371):22-24.PubMedGoogle ScholarCrossref
4.
Elsabbagh  M, Divan  G, Koh  YJ,  et al.  Global prevalence of autism and other pervasive developmental disorders.  Autism Res. 2012;5(3):160-179.PubMedGoogle ScholarCrossref
5.
Perou  R, Bitsko  RH, Blumberg  SJ,  et al; Centers for Disease Control and Prevention (CDC).  Mental health surveillance among children: United States, 2005-2011.  MMWR Surveill Summ. 2013;62(suppl 2):1-35.PubMedGoogle Scholar
6.
Kim  YS, Leventhal  BL, Koh  YJ,  et al.  Prevalence of autism spectrum disorders in a total population sample.  Am J Psychiatry. 2011;168(9):904-912.PubMedGoogle ScholarCrossref
7.
Rice  CE, Rosanoff  M, Dawson  G,  et al.  Evaluating changes in the prevalence of the autism spectrum disorders (ASDs).  Public Health Rev. 2013;34(2):1-22.Google Scholar
8.
Wakefield  AJ, Murch  SH, Anthony  A,  et al.  Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children [published retraction in Lancet. 2004;363(9411):750 and Lancet. 2010;375(9713):445].  Lancet. 1998;351(9103):637-641.PubMedGoogle ScholarCrossref
9.
McIntyre  P, Leask  J.  Improving uptake of MMR vaccine.  BMJ. 2008;336(7647):729-730.PubMedGoogle ScholarCrossref
11.
Pepys  MB.  Science and serendipity.  Clin Med. 2007;7(6):562-578.PubMedGoogle ScholarCrossref
12.
King  MD, Fountain  C, Dakhlallah  D, Bearman  PS.  Estimated autism risk and older reproductive age.  Am J Public Health. 2009;99(9):1673-1679.PubMedGoogle ScholarCrossref
13.
Shelton  JF, Tancredi  DJ, Hertz-Picciotto  I.  Independent and dependent contributions of advanced maternal and paternal ages to autism risk.  Autism Res. 2010;3(1):30-39.PubMedGoogle Scholar
14.
Schieve  LA, Rice  C, Devine  O,  et al.  Have secular changes in perinatal risk factors contributed to the recent autism prevalence increase? development and application of a mathematical assessment model.  Ann Epidemiol. 2011;21(12):930-945.PubMedGoogle ScholarCrossref
15.
Parner  ET, Schendel  DE, Thorsen  P.  Autism prevalence trends over time in Denmark: changes in prevalence and age at diagnosis.  Arch Pediatr Adolesc Med. 2008;162(12):1150-1156.PubMedGoogle ScholarCrossref
16.
Parner  ET, Thorsen  P, Dixon  G,  et al.  A comparison of autism prevalence trends in Denmark and Western Australia.  J Autism Dev Disord. 2011;41(12):1601-1608.PubMedGoogle ScholarCrossref
17.
King  M, Bearman  P.  Diagnostic change and the increased prevalence of autism.  Int J Epidemiol. 2009;38(5):1224-1234.PubMedGoogle ScholarCrossref
18.
Hertz-Picciotto  I, Delwiche  L.  The rise in autism and the role of age at diagnosis.  Epidemiology. 2009;20(1):84-90.PubMedGoogle ScholarCrossref
19.
Nassar  N, Dixon  G, Bourke  J,  et al.  Autism spectrum disorders in young children: effect of changes in diagnostic practices.  Int J Epidemiol. 2009;38(5):1245-1254.PubMedGoogle ScholarCrossref
20.
Lauritsen  MB, Pedersen  CB, Mortensen  PB.  The incidence and prevalence of pervasive developmental disorders: a Danish population-based study.  Psychol Med. 2004;34(7):1339-1346.PubMedGoogle ScholarCrossref
21.
Keyes  KM, Susser  E, Cheslack-Postava  K, Fountain  C, Liu  K, Bearman  PS.  Cohort effects explain the increase in autism diagnosis among children born from 1992 to 2003 in California.  Int J Epidemiol. 2012;41(2):495-503.PubMedGoogle ScholarCrossref
22.
Carstensen  B.  Age-period-cohort models for the Lexis diagram.  Stat Med. 2007;26(15):3018-3045.PubMedGoogle ScholarCrossref
23.
Holford  TR.  The estimation of age, period and cohort effects for vital rates.  Biometrics. 1983;39(2):311-324.PubMedGoogle ScholarCrossref
24.
Mors  O, Perto  GP, Mortensen  PB.  The Danish Psychiatric Central Research Register.  Scand J Public Health. 2011;39(7)(suppl):54-57.PubMedGoogle ScholarCrossref
25.
Knudsen  LB, Olsen  J.  The Danish Medical Birth Registry.  Dan Med Bull. 1998;45(3):320-323.PubMedGoogle Scholar
26.
Pedersen  CB.  The Danish civil registration system.  Scand J Public Health. 2011;39(7)(suppl):22-25.PubMedGoogle ScholarCrossref
27.
Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators; Centers for Disease Control and Prevention.  Prevalence of autism spectrum disorders: Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008.  MMWR Surveill Summ. 2012;61(3):1-19.PubMedGoogle Scholar
28.
Lauritsen  MB, Jørgensen  M, Madsen  KM,  et al.  Validity of childhood autism in the Danish Psychiatric Central Register: findings from a cohort sample born 1990-1999.  J Autism Dev Disord. 2010;40(2):139-148.PubMedGoogle ScholarCrossref
29.
Petersen  DJ, Bilenberg  N, Hoerder  K, Gillberg  C.  The population prevalence of child psychiatric disorders in Danish 8- to 9-year-old children.  Eur Child Adolesc Psychiatry. 2006;15(2):71-78.PubMedGoogle ScholarCrossref
30.
Yeargin-Allsopp  M, Rice  C, Karapurkar  T, Doernberg  N, Boyle  C, Murphy  C.  Prevalence of autism in a US metropolitan area.  JAMA. 2003;289(1):49-55.PubMedGoogle ScholarCrossref
31.
Centers for Disease Control and Prevention.  Autism spectrum disorders (ASDs): data & statistics.http://www.cdc.gov/ncbddd/autism/data.html. Accessed January 22, 2014.
Original Investigation
January 2015

Explaining the Increase in the Prevalence of Autism Spectrum Disorders: The Proportion Attributable to Changes in Reporting Practices

Author Affiliations
  • 1Section for Biostatistics, Department of Public Health, Aarhus University, Aarhus, Denmark
  • 2Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark
  • 3National Centre for Register-Based Research, Department of Economics and Business, Aarhus University, Aarhus, Denmark
  • 4Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark
JAMA Pediatr. 2015;169(1):56-62. doi:10.1001/jamapediatrics.2014.1893
Abstract

Importance  The prevalence of autism spectrum disorders (ASDs) has increased markedly in recent decades, which researchers have suggested could be caused in part by nonetiologic factors such as changes in diagnosis reporting practices. To our knowledge, no study has quantified the degree to which changes in reporting practices might explain this increase. Danish national health registries have undergone a change in diagnostic criteria in 1994 and the inclusion of outpatient contacts to health registries in 1995.

Objective  To quantify the effect of changes in reporting practices in Denmark on reported ASD prevalence.

Design, Setting, and Participants  We used a population-based birth cohort approach that includes information on all individuals with permanent residence in Denmark. We assessed all children born alive from January 1, 1980, through December 31, 1991, in Denmark (n = 677 915). The children were followed up from birth until ASD diagnosis, death, emigration, or the end of follow-up on December 31, 2011, whichever occurred first. The analysis uses a stratified Cox proportional hazards regression model with the changes in reporting practices modeled as time-dependent covariates.

Exposures  The change in diagnostic criteria in 1994 and the inclusion of outpatient diagnoses in 1995.

Main Outcomes and Measures  Autism spectrum disorders.

Results  For Danish children born during the study period, 33% (95% CI, 0%-70%) of the increase in reported ASD prevalence could be explained by the change in diagnostic criteria alone; 42% (95% CI, 14%-69%), by the inclusion of outpatient contacts alone; and 60% (95% CI, 33%-87%), by the change in diagnostic criteria and the inclusion of outpatient contacts.

Conclusions and Relevance  Changes in reporting practices can account for most (60%) of the increase in the observed prevalence of ASDs in children born from 1980 through 1991 in Denmark. Hence, the study supports the argument that the apparent increase in ASDs in recent years is in large part attributable to changes in reporting practices.

×